We have furthermore validated synergism between Ven/Aza and WT1-TCB in cytotoxicity experiments with OCI-AML3 cells and T cells isolated from three AML patients obtained after their first cycle of Ven/Aza. The gene discussed is WT1; the disease is acute myeloid leukemia.